Cite
HARVARD Citation
Martini, D. et al. (2021). Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer treatment and research communications. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Martini, D. et al. (2021). Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer treatment and research communications. p. . [Online].